Long-term Safety of Dasatinib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Completed · Phase 2
Conditions studied: Leukemia
In brief
This study assesses the long-term safety and tolerability of dasatinib administered to patients with chronic myelogenous leukemia or Philadelphia chromosome positive acute lymphoblastic leukemia and experienced clinical benefit from treatment with dasatinib or imatinib in previous protocols.
Key facts
- Study ID
- NCT00982488
- Run by
- Bristol-Myers Squibb
- People needed
- 238
- Starts
- 2007-10-01
- Expected to finish
- 2014-12-01
- Last updated by the study team
- 2016-01-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Loma Linda University Cancer Center — Loma Linda, California, United States
- Ucla Department Of Medicine — Los Angeles, California, United States
- Stanford University School Of Medicine — Stanford, California, United States
- Kaiser Permanente Medical Center — Vallejo, California, United States
- H. Lee Moffitt Cancer Center & Research Institute — Tampa, Florida, United States
- University Of Chicago — Chicago, Illinois, United States
- Central Indiana Cancer Centers — Indianapolis, Indiana, United States
- University Of Kansas Medical Center — Westwood, Kansas, United States
- Dana Faber Cancer Institute — Boston, Massachusetts, United States
- University Of Michigan Medical Center — Ann Arbor, Michigan, United States
- Wayne State University — Detroit, Michigan, United States
- John Theurer Cancer Center — Hackensack, New Jersey, United States
- Oregon Health & Sci Univ — Portland, Oregon, United States
- Western Pennsylvania Hospital — Pittsburgh, Pennsylvania, United States
- Ut Southwestern Medical Center At Dallas — Dallas, Texas, United States
- The University Of Texas Md Anderson Cancer Center — Houston, Texas, United States
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Buenos Aires, Buenos Aires, Argentina
- Local Institution — Capital Federal, Buenos Aires, Argentina
- Local Institution — Adelaide, South Australia, Australia
- Local Institution — Mont-godinne, Belgium
- Local Institution — Curitiba, Paraná, Brazil
- Local Institution — Rio de Janeiro, Rio de Janeiro, Brazil
- Local Institution — Campinas, São Paulo, Brazil
- Pacific Cancer Medical Center Inc — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.